Product Information
TRI-LEGEST FE-28 DAY TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.7879 per EA under NDC 00555903270. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Oct 26, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00555903270
Classification
Generic
Dosage Form
KIT
Effective Date
8/19/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA076105FDA Approved
10/26/2007
TE Code
AB
On Market Since
10/26/2007
Price Statistics
The NADAC for TRI-LEGEST FE-28 DAY TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 35.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7879 per EA |
|---|---|
| All-time high | $1.6913 (Mar 13, 2019) |
| All-time low | $0.5989 (Jul 17, 2024) |
| 52-week high | $1.1890 |
| 52-week low | $0.7879 |
| Median price | $1.1847 |
| Average price | $1.1700 |
| Largest weekly change | +48.5% (Jan 23, 2019) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Norethindrone Acetate and Ethinyl Estradiol market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TRI-LEGEST FE-28 DAY TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TRI-LEGEST FE-28 DAY TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.7879 per EA (NDC 00555903270), effective Aug 19, 2026.
How has the price of TRI-LEGEST FE-28 DAY TABLET changed over time?
Over the history we have for it, the NADAC for TRI-LEGEST FE-28 DAY TABLET has declined 35.5%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for TRI-LEGEST FE-28 DAY TABLET?
Since Nov 28, 2013, the NADAC for TRI-LEGEST FE-28 DAY TABLET has ranged from a low of $0.5989 (Jul 17, 2024) to a high of $1.6913 (Mar 13, 2019), with a median of $1.1847 per EA.
Are there cheaper alternatives to TRI-LEGEST FE-28 DAY TABLET?
No other NADAC-published product currently shares the active ingredient and strength of TRI-LEGEST FE-28 DAY TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures TRI-LEGEST FE-28 DAY TABLET?
TRI-LEGEST FE-28 DAY TABLET (NDC 00555903270) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.